TABLE OF CONTENTS

1 INTRODUCTION 8
1.1 OBJECTIVES OF THE STUDY 9
1.2 MARKET SEGMENTATION & COVERAGE 10
2 RESEARCH METHODOLOGY 11
2.1 INTEGRATED ECOSYSTEM OF INTRAUTERINE CONTRACEPTIVE DEVICES MARKET 11
2.2 ARRIVING AT THE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET SIZE 12
2.2.1 TOP-DOWN APPROACH 12
2.2.2 BOTTOM-UP APPROACH 12
2.2.3 MACRO INDICATOR-BASED APPROACH 14
2.3 ASSUMPTIONS 14
3 EXECUTIVE SUMMARY 16
4 MARKET OVERVIEW 18
4.1 INTRODUCTION 18
4.2 MARKET DRIVERS and INHIBITORS 19
4.3 KEY MARKET DYNAMICS 23
5 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 26
5.1 INTRODUCTION 27
5.2 COPPER IUD 27
5.3 HORMONAL IUD 28
5.4 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, TYPE COMPARISON WITH FEMALE CONTRACEPTIVES MARKET 29
5.5 NORTH AMERICA hormonal iud MARKET, BY country 30
5.6 NORTH AMERICA COPPER IUD MARKET, BY COUNTRY 31
6 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY PRODUCT 32
6.1 MIRENA 32
6.1.1 PRODUCT POSITIONING AND PROMOTIONS OF MIRENA 33
6.2 SKYLA 34
6.2.1 PRODUCT POSITIONING AND PROMOTIONS OF SKYLA 35
6.3 PARAGARD 36
6.3.1 PRODUCT POSITIONING AND PROMOTIONS OF PARAGARD 37
6.4 ESSURE 38
6.4.1 PRODUCT POSITIONING AND PROMOTIONS OF ESSURE 38

6.5 PIPELINE PRODUCTS 39
6.5.1 LEVOSERT 40
7 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET,
BY GEOGRAPHY 42
7.1 INTRODUCTION 43
7.2 U.S. INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET 44
7.2.1 U.S. INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET, BY TYPE 45
7.2.2 U.S. INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 47
7.3 CANADA intra-uterine contraceptice devices MARKET 49
7.3.1 CANADA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE 50
8 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: COMPETITIVE LANDSCAPE 51
8.1 U.S. INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS 51
8.2 CANADA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: COMPANY SHARE ANALYSIS 52
8.3 MERGERS & ACQUISITIONS 53
8.4 REGULATORY APPROVALS 53
8.5 PARTNERSHIP 54
8.6 COLLABORATION 54
9 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY COMPANY 55
9.1 BAYER HEALTHCARE AG (SUBSIDIARY OF BAYER AG) 55
9.1.1 OVERVIEW 55
9.1.2 KEY FINANCIALS 56
9.1.3 PRODUCT PORTFOLIO 56
9.1.4 RELATED DEVELOPMENTS 57
9.1.5 SWOT ANALYSIS 58
9.2 TEVA PHARMACEUTICAL INDUSTRIES LTD. 59
9.2.1.1 OVERVIEW 59
9.2.2 PRODUCT PORTFOLIO 60
9.2.3 SWOT ANALYSIS 61
9.3 ACTAVIS PLC 62
9.3.1 OVERVIEW 62
9.3.2 PRODUCT AND SERVICE OFFERINGS 63
9.3.3 RELATED DEVELOPMENTS 63
9.4 MEDICINES360 64
9.4.1 OVERVIEW 64
9.4.2 FINANCIALS 64
9.4.3 PRODUCT AND SERVICE OFFERINGS 64
9.4.4 RELATED DEVELOPMENTS 64
9.5 TRIMEDIC SUPPLY NETWORK LTD. 65
9.5.1 OVERVIEW 65
9.5.2 FINANCIALS 65
9.5.3 PRODUCTS AND SERVICE OFFERINGS 65
9.6 MEDISAFE DISTRIBUTION INC. 66
9.6.1 OVERVIEW 66
9.6.2 FINANCIALS 66
9.6.3 PRODUCT AND SERVICES OFFERINGS 66
9.6.4 RELATED DEVELOPMENTS 66
9.7 PACE PHARMACEUTICALS, INC. 67
9.7.1 OVERVIEW 67
9.7.2 FINANCIALS 67
9.7.3 PRODUCTS 67
9.7.4 RELATED DEVELOPMENTS 67
10 APPENDIX 68
10.1 RELATED REPORTS 68
10.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 68
10.2.1 RT SNAPSHOTS 69



LIST OF TABLES


TABLE 1 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: MACRO INDICATORS, BY COUNTRY, 2013 (ABORTION PER 1000 WOMEN AGES 15-44) 14
TABLE 2 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: DRIVERS AND INHIBITORS 19
TABLE 3 GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: COMPARISION WITH GLOBAL FEMALE CONTRACEPTIVES MARKET, 2013-2019 (USD MN) 23
TABLE 4 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY COUNTRY, 2013-2019 (USD MN) 24
TABLE 5 NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, BY TYP,
2013-2019 (USD MN) 25
TABL